Company Search:
Advanced Search
Sponsored Links
Addex Therapeutics Company Snapshot
Addex Therapeutics operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Addex Therapeutics with three other pharmaceutical manufacturers in Europe: Polyphor AG (2018 sales of 6.55 million Swiss Francs [US$6.79 million] of which 100% was Pharma Business), Biotec Pharmacon ASA of Norway (66.77 million Norwegian Kroner [US$7.50 million] of which 51% was Enzymes), and Onxeo SA which is based in France (6.13 million Euro [US$6.80 million] of which 91% was Operating segment -Rest of the world).

Sales Analysis. Sales increased substantially in 2018: Addex Therapeutics reported sales of 6.70 million Swiss Francs (US$6.95 million) for the year ending December of 2018. This represents an increase of 1,240.8% versus 2017, when the company's sales were 499,894.00 Swiss Francs. This was the third consecutive year of growth at Addex Therapeutics.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Addex Therapeutics
  Stock Performance Chart for Addex Therapeutics
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 2.12
(Figures in Swiss Francs)
1 Week 18.4%   13 Weeks 28.5%  
4 Weeks 22.2%   52 Weeks -7.4%  
Addex Therapeutics Key Data:
  Ticker: ADXN Country: Switzerland
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 6,702,673
(Year Ending Jan 2019).
Employees: 17
  Currency: Swiss Francs Market Cap: 56,148,452
  Fiscal Yr Ends: December Shares Outstanding: 26,485,119
  Share Type: Namenaktie Closely Held Shares: 2,000,274
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.